Syndax Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell SNDX and other ETFs, options, and stocks.

About SNDX

Syndax Pharmaceuticals, Inc. engages in the development of cancer therapies. Its products include Revuforj and Niktimvo. 

CEO
Michael A. Metzger
CEOMichael A. Metzger
Employees
298
Employees298
Headquarters
New York, New York
HeadquartersNew York, New York
Founded
2005
Founded2005
Employees
298
Employees298

SNDX Key Statistics

Market cap
1.22B
Market cap1.22B
Price-Earnings ratio
-5.42
Price-Earnings ratio-5.42
Dividend yield
—
Dividend yield—
Average volume
2.49M
Average volume2.49M
High today
—
High today—
Low today
—
Low today—
Open price
$13.60
Open price$13.60
Volume
0.00
Volume0.00
52 Week high
$25.59
52 Week high$25.59
52 Week low
$12.99
52 Week low$12.99

Stock Snapshot

Syndax Pharmaceuticals(SNDX) stock is priced at $13.78, giving the company a market capitalization of 1.22B. It carries a P/E multiple of -5.42.

On 2026-10-16, Syndax Pharmaceuticals(SNDX) stock opened at $13.60, reached a high of —, and a low of —.

Syndax Pharmaceuticals(SNDX) shares are trading with a volume of 0, against a daily average of 2.49M.

During the past year, Syndax Pharmaceuticals(SNDX) stock moved between $12.99 at its lowest and $25.59 at its peak.

During the past year, Syndax Pharmaceuticals(SNDX) stock moved between $12.99 at its lowest and $25.59 at its peak.

SNDX News

TIME 1d
Syndax Revuforj: The Best Inventions of 2026 - Time Magazine

...

Syndax Revuforj: The Best Inventions of 2026 - Time Magazine

Analyst ratings

100%

of 12 ratings
Buy
100%
Hold
0%
Sell
0%

People also own

Based on the portfolios of people who own SNDX. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.